Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epigallocatechin gallate (EGCG) is a naturally occurring polyphenolic compound, specifically a catechin, most abundantly found in green tea leaves. It is widely studied for its potential health benefits and biological activities, including antioxidant, anti-inflammatory, antimutagenic, and antitumor properties. EGCG interacts with various molecular targets involved in cancer progression, inflammation, and other disease processes. Oral bioavailability is low, and high dosages may cause gastrointestinal side effects.
EGCG exhibits pleiotropic mechanisms of action, including antioxidant and anti-inflammatory effects. It interacts with several molecular targets, such as the 67-kDa Laminin Receptor (67LR), Pin1, TGFβ Receptor II, MMPs (MMP2/MMP9), and DNA methyltransferases/HDACs. These interactions modulate cellular signaling pathways involved in cancer cell viability, progression, metastasis, and invasion. EGCG also acts as an inhibitor of Hsp90 and induces apoptosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epigallocatechin gallate (EGCG).